Synergistic inactivation of AXL: a (cross)road to cure ovarian cancer?

Autor: Chiara Zurzolo
Přispěvatelé: Trafic membranaire et Pathogénèse, Institut Pasteur [Paris] (IP), The author is grateful to Simona Paladino and Stephanie Lebreton for the critical discussion of the literature and to all members of the Zurzolo laboratory for their work, enthusiasm and continuous support., ANR-16-CE16-0020,nicostress,Réseaux neuronaux sous-tendant l'intéraction entre stress et nicotine dans le cadre des troubles psychiatriques(2016), ANR-16-CE16-0019,Neurotunn,Role des nanotubes membranaires dans la propagation d'agrégats protéiques impliqués dans les maladie neurodégénératives(2016), Zurzolo, C., Institut Pasteur [Paris]
Jazyk: angličtina
Rok vydání: 2018
Předmět:
0301 basic medicine
Biochemistry
Receptor tyrosine kinase
law.invention
Cell Movement
law
News & Views
Phosphorylation
Therapeutic strategy
Ovarian Neoplasms
biology
Kinase
Chemistry
Receptor-Like Protein Tyrosine Phosphatases
Class 5

GPI-Linked Protein
3. Good health
Benzocycloheptenes
MESH: Ovarian Neoplasms
Cholesterol
Treatment Outcome
MESH: Cell Adhesion Molecules
Intercellular Signaling Peptides and Proteins
MESH: Phosphoric Monoester Hydrolases
Female
Protein Binding
Human
Cell Survival
MAP Kinase Signaling System
Phosphatase
[SDV.CAN]Life Sciences [q-bio]/Cancer
Phosphoric Monoester Hydrolase
MESH: Receptor-Like Protein Tyrosine Phosphatases
Class 5

GPI-Linked Proteins
Malignancy
Dephosphorylation
03 medical and health sciences
Membrane Microdomains
Cell Line
Tumor

Proto-Oncogene Proteins
Genetics
medicine
Animals
Humans
Neoplasm Invasiveness
Gene Silencing
Molecular Biology
Fallopian Tubes
MESH: Humans
Tumor Suppressor Proteins
Ovarian Neoplasm
Receptor Protein-Tyrosine Kinases
Epithelial Cells
Triazoles
medicine.disease
Axl Receptor Tyrosine Kinase
Enzyme Activation
MESH: Proto-Oncogene Proteins
030104 developmental biology
Cell Adhesion Molecule
Cancer research
biology.protein
Suppressor
MESH: GPI-Linked Proteins
Ovarian cancer
Cell Adhesion Molecules
Chickens
MESH: Female
Zdroj: EMBO Reports
EMBO Reports, 2018, 19 (8), pp.e46492. ⟨10.15252/embr.201846492⟩
EMBO Reports, EMBO Press, 2018, 19 (8), pp.e46492. ⟨10.15252/embr.201846492⟩
ISSN: 1469-221X
1469-3178
DOI: 10.15252/embr.201846492⟩
Popis: In ovarian cancer, the prometastatic RTK AXL promotes motility, invasion and poor prognosis. Here, we show that reduced survival caused by AXL overexpression can be mitigated by the expression of the GPI-anchored tumour suppressor OPCML Further, we demonstrate that AXL directly interacts with OPCML, preferentially so when AXL is activated by its ligand Gas6. As a consequence, AXL accumulates in cholesterol-rich lipid domains, where OPCML resides. Here, phospho-AXL is brought in proximity to the lipid domain-restricted phosphatase PTPRG, which de-phosphorylates the RTK/ligand complex. This prevents AXL-mediated transactivation of other RTKs (cMET and EGFR), thereby inhibiting sustained phospho-ERK signalling, induction of the EMT transcription factor Slug, cell migration and invasion. From a translational perspective, we show that OPCML enhances the effect of the phase II AXL inhibitor R428
Databáze: OpenAIRE